Long-term Cardiovascular Risk in Cured Cushing's Patients
This study has been withdrawn prior to enrollment.
(No patients were enrolled.)
Information provided by (Responsible Party):
Anne Klibanski, MD, Massachusetts General Hospital
First received: April 13, 2009
Last updated: April 29, 2015
Last verified: April 2015
The purpose of this study is to determine whether subjects who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.
||Observational Model: Case Control
Time Perspective: Cross-Sectional
||Role of Adipokines in Long-term Cardiovascular Risk in Cured Cushing's Patients
Biospecimen Retention: Samples With DNA
Primary Outcome Measures:
- adipokine measurements [ Time Frame: baseline ] [ Designated as safety issue: No ]
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||October 2009 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||35 Years to 55 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- patients who have been cured of Cushing's disease at least 5 years ago.
- patients who have been cured of Cushing's disease more than 15 years ago.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00881283
|Neuroendocrine Clinical Center
|Boston, Massachusetts, United States, 02114 |
Massachusetts General Hospital
||Anne Klibanski, MD
||Massachusetts General Hospital
No publications provided
||Anne Klibanski, MD, PI, Massachusetts General Hospital
History of Changes
|Other Study ID Numbers:
|Study First Received:
||April 13, 2009
||April 29, 2015
||United States: Institutional Review Board
Keywords provided by Massachusetts General Hospital:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 01, 2015
Pituitary ACTH Hypersecretion
Adrenal Gland Diseases
Central Nervous System Diseases
Endocrine System Diseases
Nervous System Diseases